Elisa Bossi
Monza, 20900, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial.
Journal: HemaSphere
Published: April 02, 2026
Anaplastic Lymphoma Kinase (ALK) Inhibitors Enhance Phagocytosis Induced by CD47 Blockade in Sensitive and Resistant ALK-Driven Malignancies.
Journal: Biomedicines
Published: September 22, 2024
Effects of blocking CD24 and CD47 'don't eat me' signals in combination with rituximab in mantle-cell lymphoma and chronic lymphocytic leukaemia.
Journal: Journal of cellular and molecular medicine
Published: February 17, 2023
Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.
Journal: Hematological oncology
Published: September 11, 2020
Phase two study of crizotinib in patients with anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma relapsed/refractory to chemotherapy.
Journal: American journal of hematology
Published: August 06, 2020
An Imatinib-non-responsive patient with an ABL Leu387Trp mutation achieves cytogenetic and molecular response under bosutinib: Case report and biological characterization.
Journal: Clinical case reports
Published: June 20, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026